{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T10:08:52Z","timestamp":1783937332886,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T00:00:00Z","timestamp":1504569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Liver fibrosis must be evaluated in patients with hepatitis C virus (HCV) after liver transplantation because its severity affects their prognosis and the recurrence of HCV. Since invasive biopsy is still the gold standard to identify patients at risk of graft loss from rapid fibrosis progression, it becomes crucial the development of new accurate, non-invasive methods that allow repetitive examination of the patients. Therefore, we have developed a non-invasive, accurate model to distinguish those patients with different liver fibrosis stages. Two hundred and three patients with HCV were histologically classified (METAVIR) into five categories of fibrosis one year after liver transplantation. In this cross-sectional study, patients at fibrosis stages F0-F1 (n\u2009=\u2009134) were categorised as \u201cslow fibrosers\u201d and F2-F4 (n\u2009=\u200969) as \u201crapid fibrosers\u201d. Chloroform\/methanol serum extracts were analysed by reverse ultra-high performance liquid chromatography coupled to mass spectrometry. A diagnostic model was built through linear discriminant analyses. An algorithm consisting of two sphingomyelins and two phosphatidylcholines accurately classifies rapid and slow fibrosers after transplantation. The proposed model yielded an AUROC of 0.92, 71% sensitivity, 85% specificity, and 84% accuracy. Moreover, specific bile acids and sphingomyelins increased notably along with liver fibrosis severity, differentiating between rapid and slow fibrosers.<\/jats:p>","DOI":"10.1038\/s41598-017-10807-y","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T11:07:53Z","timestamp":1504091273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6019-8926","authenticated-orcid":false,"given":"Ainara","family":"Cano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Mari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Millet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibon","family":"Mart\u00ednez-Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Navasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Falc\u00f3n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"P\u00e9rez-Cormenzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Caballer\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieves","family":"Embade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azucena","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Mato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"10807_CR1","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet CN \n                           380, 2095\u20132128 (2012).","journal-title":"Lancet CN"},{"key":"10807_CR2","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C. & Roudot-Thoraval, F. The burden of liver disease in Europe: A review of available epidemiological data. J. Hepatol. \n                           58, 593\u2013608 (2013).","journal-title":"J. Hepatol."},{"key":"10807_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2893.2009.01222.x","volume":"17","author":"TJS Cross","year":"2010","unstructured":"Cross, T. J. S. et al. A simple, noninvasive test for the diagnosis of liver fibrosis in patients with hepatitis C recurrence after liver transplantation. J. Viral Hepat. \n                           17, 640\u2013649 (2010).","journal-title":"J. Viral Hepat."},{"key":"10807_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1053\/jhep.2002.31773","volume":"35","author":"M Garcia-Retortillo","year":"2002","unstructured":"Garcia-Retortillo, M. et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology \n                           35, 680\u2013687 (2002).","journal-title":"Hepatology"},{"key":"10807_CR5","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1053\/gast.2002.32418","volume":"122","author":"LM Forman","year":"2002","unstructured":"Forman, L. M., Lewis, J. D., Berlin, J. A., Feldman, H. I. & Lucey, M. R. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology \n                           122, 889\u2013896 (2002).","journal-title":"Gastroenterology"},{"key":"10807_CR6","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.hep.2003.09.022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa, P., Dargere, D. & Paradis, V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology \n                           38, 1449\u201357 (2003).","journal-title":"Hepatology"},{"key":"10807_CR7","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/tid.12526","volume":"18","author":"G Crespo","year":"2016","unstructured":"Crespo, G. et al. Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation. Transpl. Infect. Dis. \n                           18, 471\u2013479 (2016).","journal-title":"Transpl. Infect. Dis."},{"key":"10807_CR8","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver & Asociaci\u00f3n Latinoamericana para el Estudio del H\u00edgado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J. Hepatol. 63, 237\u2013264 (2015).","DOI":"10.1016\/j.jhep.2015.04.006"},{"key":"10807_CR9","doi-asserted-by":"publisher","first-page":"11567","DOI":"10.3748\/wjg.v21.i41.11567","volume":"21","author":"Y Lurie","year":"2015","unstructured":"Lurie, Y., Webb, M., Cytter-Kuint, R., Shteingart, S. & Lederkremer, G. Z. Non-invasive diagnosis of liver fibrosis and cirrhosis. World J. Gastroenterol. \n                           21, 11567\u201311583 (2015).","journal-title":"World J. Gastroenterol."},{"key":"10807_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/hep.24013","volume":"53","author":"SM Mart\u00ednez","year":"2011","unstructured":"Mart\u00ednez, S. M. et al. Noninvasive assessment of liver fibrosis. Hepatology \n                           53, 325\u2013335 (2011).","journal-title":"Hepatology"},{"key":"10807_CR11","first-page":"218","volume":"25","author":"V Papastergiou","year":"2012","unstructured":"Papastergiou, V., Tsochatzis, E. & Burroughs, A. K. Non-invasive assessment of liver fibrosis. Ann. Gastroenterol. \n                           25, 218\u2013231 (2012).","journal-title":"Ann. Gastroenterol."},{"key":"10807_CR12","doi-asserted-by":"publisher","first-page":"S501","DOI":"10.1007\/s12072-015-9700-7","volume":"10","author":"L Castera","year":"2016","unstructured":"Castera, L. Non-invasive tests for liver fibrosis: EASL Clinical Practice Guidelines and future directions. Hepatol. Int. \n                           10, S501\u2013S502 (2016).","journal-title":"Hepatol. Int."},{"key":"10807_CR13","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1373\/clinchem.2005.048389","volume":"51","author":"LA Adams","year":"2005","unstructured":"Adams, L. A. et al. Hepascore: An accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin. Chem. \n                           51, 1867\u20131873 (2005).","journal-title":"Clin. Chem."},{"key":"10807_CR14","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/hep.20935","volume":"42","author":"P Cal\u00e8s","year":"2005","unstructured":"Cal\u00e8s, P. et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology \n                           42, 1373\u20131381 (2005).","journal-title":"Hepatology"},{"key":"10807_CR15","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/hep.22099","volume":"47","author":"RJ Fontana","year":"2008","unstructured":"Fontana, R. J. et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology \n                           47, 789\u2013798 (2008).","journal-title":"Hepatology"},{"key":"10807_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","volume":"21","author":"GH Syed","year":"2010","unstructured":"Syed, G. H., Amako, Y. & NIH, S. A. Public Access. Trends Endocrinol Metab \n                           21, 33\u201340 (2010).","journal-title":"Trends Endocrinol Metab"},{"key":"10807_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-7-13","volume":"7","author":"S Mirandola","year":"2010","unstructured":"Mirandola, S., Bowman, D., Hussain, M. M. & Alberti, A. Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP). Nutr. Metab. (Lond). \n                           7, 13 (2010).","journal-title":"Nutr. Metab. (Lond)."},{"key":"10807_CR18","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/oby.2009.326","volume":"18","author":"A Kotronen","year":"2010","unstructured":"Kotronen, A. et al. Comparison of lipid and fatty acid composition of the liver, subcutaneous and intra-abdominal adipose tissue, and serum. Obesity (Silver Spring). \n                           18, 937\u2013944 (2010).","journal-title":"Obesity (Silver Spring)."},{"key":"10807_CR19","doi-asserted-by":"crossref","unstructured":"Embade, N. et al. Metabolic characterization of advanced liver fibrosis in HCV patients as studied by serum 1H-NMR spectroscopy. PLoS One \n                           11, (2016).","DOI":"10.1371\/journal.pone.0155094"},{"key":"10807_CR20","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1042\/BST20140138","volume":"42","author":"A Cano","year":"2014","unstructured":"Cano, A. & Alonso, C. Deciphering non-alcoholic fatty liver disease through metabolomics. Biochem. Soc. Trans. \n                           42, 1447\u20131452 (2014).","journal-title":"Biochem. Soc. Trans."},{"key":"10807_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/hep.26399","volume":"58","author":"M Mart\u00ednez-U\u00f1a","year":"2013","unstructured":"Mart\u00ednez-U\u00f1a, M. et al. Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology \n                           58, 1296\u20131305 (2013).","journal-title":"Hepatology"},{"key":"10807_CR22","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","volume":"29","author":"JK Nicholson","year":"1999","unstructured":"Nicholson, J. K., Lindon, J. C. & Holmes, E. \u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica \n                           29, 1181\u20131189 (1999).","journal-title":"Xenobiotica"},{"key":"10807_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.chemphyslip.2015.08.018","volume":"197","author":"Y Uto","year":"2016","unstructured":"Uto, Y. Recent progress in the discovery and development of stearoyl CoA desaturase inhibitors. Chem. Phys. Lipids \n                           197, 3\u201312 (2016).","journal-title":"Chem. Phys. Lipids"},{"key":"10807_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep12466","volume":"5","author":"K Saito","year":"2015","unstructured":"Saito, K. et al. Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis. Sci. Rep. \n                           5, 12466 (2015).","journal-title":"Sci. Rep."},{"key":"10807_CR25","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s11306-011-0329-9","volume":"8","author":"E Gonzalez","year":"2012","unstructured":"Gonzalez, E. et al. Serum UPLC-MS\/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity. Metabolomics \n                           8, 997\u20131011 (2012).","journal-title":"Metabolomics"},{"key":"10807_CR26","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.18632\/oncotarget.3191","volume":"6","author":"L Barbier-Torres","year":"2015","unstructured":"Barbier-Torres, L. et al. Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Oncotarget \n                           6, 2509\u201323 (2015).","journal-title":"Oncotarget"},{"key":"10807_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.copbio.2016.10.003","volume":"43","author":"A Nguyen","year":"2017","unstructured":"Nguyen, A., Rudge, S. A., Zhang, Q. & Wakelam, M. J. Using lipidomics analysis to determine signalling and metabolic changes in cells. Curr. Opin. Biotechnol. \n                           43, 96\u2013103 (2017).","journal-title":"Curr. Opin. Biotechnol."},{"key":"10807_CR28","doi-asserted-by":"publisher","unstructured":"Gao, R. et al. Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma. Nat. Publ. Gr. 1\u201310 (2015). doi:10.1038\/srep18175","DOI":"10.1038\/srep18175"},{"key":"10807_CR29","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1021\/pr201223p","volume":"11","author":"J Barr","year":"2012","unstructured":"Barr, J. et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J. Proteome Res. \n                           11, 2521\u20132532 (2012).","journal-title":"J. Proteome Res."},{"key":"10807_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep31587","volume":"6","author":"F Chiappini","year":"2016","unstructured":"Chiappini, F., Desterke, C., Bertrand-Michel, J., Guettier, C. & Le Naour, F. Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models. Sci. Rep. \n                           6, 31587 (2016).","journal-title":"Sci. Rep."},{"key":"10807_CR31","doi-asserted-by":"publisher","unstructured":"Alonso, C. et al. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. Gastroenterology (2017). doi:10.1053\/j.gastro.2017.01.015","DOI":"10.1053\/j.gastro.2017.01.015"},{"key":"10807_CR32","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/liv.12972","volume":"36","author":"S Seijo","year":"2016","unstructured":"Seijo, S. et al. Metabolomics as a diagnostic tool for idiopathic non-cirrhotic portal hypertension. Liver Int. \n                           36, 1051\u20131058 (2016).","journal-title":"Liver Int."},{"key":"10807_CR33","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/ajg.2013.11","volume":"108","author":"S Seijo","year":"2013","unstructured":"Seijo, S. et al. Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension. Am J Gastroenterol \n                           108, 926\u201332 (2013).","journal-title":"Am J Gastroenterol"},{"key":"10807_CR34","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.jhep.2016.01.003","volume":"64","author":"MJW McPhail","year":"2016","unstructured":"McPhail, M. J. W. et al. Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis. J. Hepatol. \n                           64, 1058\u20131067 (2016).","journal-title":"J. Hepatol."},{"key":"10807_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jhep.2014.04.023","volume":"61","author":"M Cortes","year":"2014","unstructured":"Cortes, M. et al. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction. J. Hepatol. \n                           61, 564\u2013574 (2014).","journal-title":"J. Hepatol."},{"key":"10807_CR36","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/MOT.0b013e32833068fb","volume":"14","author":"MM Sarwal","year":"2009","unstructured":"Sarwal, M. M. Deconvoluting the \u2018omics\u2019 for organ transplantation. Curr. Opin. Organ Transplant. \n                           14, 544\u2013551 (2009).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"10807_CR37","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1111\/j.1600-6143.2005.01119.x","volume":"5","author":"DS Wishart","year":"2005","unstructured":"Wishart, D. S. Metabolomics: the principles and potential applications to transplantation. Am J Transpl. \n                           5, 2814\u20132820 (2005).","journal-title":"Am J Transpl."},{"key":"10807_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1089\/omi.2009.0139","volume":"14","author":"O Hrydziuszko","year":"2010","unstructured":"Hrydziuszko, O. et al. Application of metabolomics to investigate the process of human orthotopic liver transplantation: a proof-of-principle study. OMICS \n                           14, 143\u2013150 (2010).","journal-title":"OMICS"},{"key":"10807_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/01.tp.0000251649.01148.f8","volume":"83","author":"NJ Serkova","year":"2009","unstructured":"Serkova, N. J. et al. Early Detection of Graft Failure Using the Blood Metabolic Profile of a Liver Recipient. Transplantation \n                           83, 517\u2013521 (2009).","journal-title":"Transplantation"},{"key":"10807_CR40","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/elps.201000512","volume":"32","author":"C Legido-Quigley","year":"2011","unstructured":"Legido-Quigley, C. et al. Bile UPLC-MS fingerprinting and bile acid fluxes during human liver transplantation. Electrophoresis \n                           32, 2063\u20132070 (2011).","journal-title":"Electrophoresis"},{"key":"10807_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11306-013-0598-6","volume":"10","author":"E Saccenti","year":"2014","unstructured":"Saccenti, E., Hoefsloot, H. J. C. J., Smilde, A. K., Westerhuis, J. A. & Hendriks, M. W. B. M. W. B. Reflections on univariate and multivariate analysis of metabolomics data. Metabolomics \n                           10, 361\u2013374 (2014).","journal-title":"Metabolomics"},{"key":"10807_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/hep.23240","volume":"51","author":"JA Carrion","year":"2010","unstructured":"Carrion, J. A. et al. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology \n                           51, 23\u201334 (2010).","journal-title":"Hepatology"},{"key":"10807_CR43","unstructured":"Hand, D. et al. Principles of data mining. Drug safety: an international journal of medical toxicology and drug experience 30, (2001)."},{"key":"10807_CR44","unstructured":"Witten, I. H. & Frank, E. Data Mining: Practical machine learning tools and techniques. Machine Learning (2005)."},{"key":"10807_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-2007-1007147","volume":"18","author":"T Patel","year":"1998","unstructured":"Patel, T., Roberts, L. R., Jones, B. A. & Gores, G. J. Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin. Liver Dis. \n                           18, 105\u2013114 (1998).","journal-title":"Semin. Liver Dis."},{"key":"10807_CR46","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1039\/b820224a","volume":"5","author":"P Yin","year":"2009","unstructured":"Yin, P. et al. A metabonomic study of hepatitis B induced liver cirrhosis and hepatocellular carcinoma by using RP-LC and HILIC coupled with mass spectrometry. Mol. Biosyst. \n                           5, 868\u2013876 (2009).","journal-title":"Mol. Biosyst."},{"key":"10807_CR47","first-page":"761","volume":"26","author":"C Zhou","year":"2013","unstructured":"Zhou, C. et al. The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice. Pak. J. Pharm. Sci. \n                           26, 761\u2013765 (2013).","journal-title":"Pak. J. Pharm. Sci."},{"key":"10807_CR48","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2353\/ajpath.2010.091257","volume":"177","author":"A Moles","year":"2010","unstructured":"Moles, A. et al. Acidic sphingomyelinase controls hepatic stellate cell activation and in vivo liver fibrogenesis. Am J Pathol \n                           177, 1214\u20131224 (2010).","journal-title":"Am J Pathol"},{"key":"10807_CR49","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/hep.27587","volume":"61","author":"G Grammatikos","year":"2015","unstructured":"Grammatikos, G. et al. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection. Hepatology \n                           61, 812\u2013822 (2015).","journal-title":"Hepatology"},{"key":"10807_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-016-0244-1","volume":"15","author":"M Ishikawa","year":"2016","unstructured":"Ishikawa, M. et al. Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in rats. Lipids Health Dis. \n                           15, 74 (2016).","journal-title":"Lipids Health Dis."},{"key":"10807_CR51","first-page":"47","volume":"284","author":"S Chen","year":"2006","unstructured":"Chen, S. & Morgan, T. The Natural History of Hepatitis C Virus. Infection. \n                           284, 47\u201352 (2006).","journal-title":"Infection."},{"key":"10807_CR52","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/hep.1840060503","volume":"6","author":"H Tsukamoto","year":"1986","unstructured":"Tsukamoto, H., Towner, S. J., Ciofalo, L. M. & French, S. W. Ethanol-induced liver fibrosis in rats fed high fat diet. Hepatology \n                           6, 814\u2013822 (1986).","journal-title":"Hepatology"},{"key":"10807_CR53","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/hep.1840030118","volume":"3","author":"R P\u00e9rez Tamayo","year":"1983","unstructured":"P\u00e9rez Tamayo, R. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology \n                           3, 112\u201320 (1983).","journal-title":"Hepatology"},{"key":"10807_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF00257314","volume":"22","author":"T Ducastelle","year":"1988","unstructured":"Ducastelle, T. et al. The hepatotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats - Ultrastructural evidence of a delayed microtubular toxicity. Cancer Chemother. Pharmacol. \n                           22, 153\u2013162 (1988).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10807_CR55","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.hepres.2005.12.006","volume":"34","author":"Q Zhang","year":"2006","unstructured":"Zhang, Q. et al. Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infection. Hepatol. Res. \n                           34, 170\u20137 (2006).","journal-title":"Hepatol. Res."},{"key":"10807_CR56","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0140-6736(79)92119-6","volume":"314","author":"JH James","year":"1979","unstructured":"James, J. H., Jeppsson, B., Ziparo, V. & Fischer, J. E. Hyperammonaemia, plasma aminoacid imbalance, and blood-brain aminoacid transport: a unified theory of portal-systemic encephalopathy. Lancet \n                           314, 772\u2013775 (1979).","journal-title":"Lancet"},{"key":"10807_CR57","first-page":"2055","volume":"60","author":"T Ishikawa","year":"2013","unstructured":"Ishikawa, T. et al. Branched-chain amino acids to tyrosine ratio (BTR) predicts intrahepatic distant recurrence and survival for early hepatocellular carcinoma. Hepatogastroenterology. \n                           60, 2055\u20132059 (2013).","journal-title":"Hepatogastroenterology."},{"key":"10807_CR58","first-page":"140","volume":"3","author":"O Mitchell","year":"2015","unstructured":"Mitchell, O. & Gurakar, A. Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review. J. Clin. Transl. Hepatol. \n                           3, 140\u20138 (2015).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10807_CR59","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa, P. & An, T. P. algorithm for the grading of activity in chronic hepatitis C. Hepatology \n                           24, 289\u2013293 (1996).","journal-title":"Hepatology"},{"key":"10807_CR60","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1021\/pr1002593","volume":"9","author":"J Barr","year":"2010","unstructured":"Barr, J. et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res \n                           9, 4501\u20134512 (2010).","journal-title":"J Proteome Res"},{"key":"10807_CR61","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/jssc.200700673","volume":"31","author":"ES Grumbach","year":"2008","unstructured":"Grumbach, E. S., Diehl, D. M. & Neue, U. D. The application of novel 1.7 microm ethylene bridged hybrid particles for hydrophilic interaction chromatography. J Sep Sci \n                           31, 1511\u20131518 (2008).","journal-title":"J Sep Sci"},{"key":"10807_CR62","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1021\/pr900499r","volume":"8","author":"FM V D Kloet","year":"2009","unstructured":"V D Kloet, F. M., Bobeldijk, I., Verheij, E. R. & Jellema, R. H. Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J. Proteome Res. \n                           8, 5132\u20135141 (2009).","journal-title":"J. Proteome Res."},{"key":"10807_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jprot.2015.01.019","volume":"127","author":"I Mart\u00ednez-Arranz","year":"2015","unstructured":"Mart\u00ednez-Arranz, I. et al. Enhancing metabolomics research through data mining. J. Proteomics \n                           127, 275\u2013288 (2015).","journal-title":"J. Proteomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10807-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10807-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T10:18:40Z","timestamp":1671790720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10807-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10807"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10807-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]},"assertion":[{"value":"27 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10497"}}